Radient Technologies Inc. Announces Director Resignation

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN UNITED STATES/

TSX Venture: RTI

EDMONTON, May 28, 2014 /CNW/ - Radient Technologies Inc. ("Radient") announces that Dr. Hans Black has resigned as a director of Radient effective immediately.  Dr. Black has determined it appropriate for him to resign from the Board of Directors of Radient while the TSX Venture Exchange (the "Exchange") completes its review of his involvement as a director of Radient pursuant to the initial listing requirements of the Exchange for Radient.  Subject to acceptance by the Exchange following completion of its review, it is intended that Dr. Black will be reappointed to Radient's Board of Directors.  The Exchange review should have no bearing on Dr. Black's roles on the board of directors of several other reporting issuers.

About Radient

Radient extracts natural ingredients and compounds from a range of biological materials using microwave assisted processing ("MAP™"), a patented platform which along with extraction expertise developed over more than a decade, provides superior outcomes for its customers in terms of purity, yield, and cost.

Radient's customers are global market leaders in industries that include pharmaceutical, food, beverage, natural health, active care and bio-fuel markets.  Working with each customer compound over three stages, scaling from initial feasibility to pilot scale to commercial production, Radient generates revenue at every phase of the customer relationship, culminating in a manufacturing agreement, a technology license, or a joint venture.

Radient commissioned its 20,000 square foot manufacturing plant in Edmonton, Alberta in January 2014 with current capacity to process commercial volumes of up five (5) tonnes of biomass per day.  Expandable to over ten (10) tonnes per day, the building and premises are owned by 1631807 Alberta Ltd., of which Radient is a 50% shareholder.

Along with the existing MAP™ technology patent, Radient has filed three (3) additional patents in connection with it, and continues to develop and file patents for incremental intellectual property developed with the technology.

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this press release.

SOURCE: Radient Technologies Inc.

please contact: Denis Taschuk, President and Chief Executive Officer of Radient, at [phone] (ext. 274).